___

• 1. World Health Organization (2011). Atlas of headache disorders and resources in the world
• Genevahttps://www.who.int/mental_health/management/wh o_atlas_headache_disorders.pdf?ua=1. Last Updated at: 4.12.2018
• 2. Lipton, R.B., Hamelsky, S.W., Kolodner, K.B., Steiner, T.J., Stewart, W.F. (2000) Migraine, quality of life, and depression. A
• population – based case-control study. Neurology. 12;(55) 5:629-35. PMID: 10980724 3. Smitherman, T.A., Burch, R., Sheik, H., Loder, E. (2013) The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 53(3):427-36. PMID: 234700015
• 4. Stewart, WF, Lipton, R.B., Dowson, A.J., Sawyer, J. (2001) Development and testing of the Migraine Disability Assessment
• (MIDAS) Questionnaire to assess headache-related disability. Neurology. 56 (6 Suppl 1): S20–8. PMID: 11294956
• 5. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict; 86: 1119-27.
• 6. Yaman M., Demirkıran M.K., Oruç S. (2007) Migrende Baş ağrısını Tetikleyici ve Kötüleştirici Faktörler. Düzce Tip Fakültesi Dergisi;3:9-13
• 7. Lopez-Mesonero L., Marquez S., Parra P., Gamez-Leyva G., Munoz P., Pascual J. (2009) Smoking as a precipitating factor
• for migraine: a survey in medical students. J Headache Pain;10:101-03.
• 8. Lassen L.H., Ashina M,. Christiansen I., Ulrich V., Olesen J. (1997). Nitric oxide synthase inhibition in migraine. Lancet. 8;349:401-2.
• 9. Chen T.C., Leviton A., Edelstein S., Ellenberg J.H. (1987) Migraine and other diseases in women of reproductive age. The influence of smoking on observed associations. ArchNeurol. ;44:1024-8.